136293-86-2 Usage
Uses
Used in Pharmaceutical Industry:
3-(METHYLAMINO)AZETIDINE DIHYDROCHLORIDE is used as a synthetic reagent for the production of novel oxazine and thiazine ring-fused tricyclic quinolonecarboxylic acids. These compounds exhibit potent bactericidal properties, making them valuable in the development of new antibiotics to combat bacterial infections.
Used in Chemical Synthesis:
In the field of chemical synthesis, 3-(METHYLAMINO)AZETIDINE DIHYDROCHLORIDE is utilized as a building block for the creation of complex organic molecules. Its unique structure allows for the formation of various heterocyclic compounds with potential applications in pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
3-(METHYLAMINO)AZETIDINE DIHYDROCHLORIDE is also employed in research and development laboratories for the study of its chemical properties and potential applications. Scientists and researchers use this compound to explore new reaction pathways, develop innovative synthetic methods, and investigate its biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 136293-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,2,9 and 3 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 136293-86:
(8*1)+(7*3)+(6*6)+(5*2)+(4*9)+(3*3)+(2*8)+(1*6)=142
142 % 10 = 2
So 136293-86-2 is a valid CAS Registry Number.
136293-86-2Relevant articles and documents
Quantitative structure-activity relationships of antibacterial agents, 7-heterocyclic amine substituted 1-cyclopropyl-6,8-difluoro-4-oxoquinoline-3-carboxylic acids
Okada,Ezumi,Yamakawa,Sato,Tsuji,Tsushima,Motokawa,Komatsu
, p. 126 - 131 (2007/10/02)
Quantitative structure-activity relationships (QSAR) of various 7-(3-substituted-azetidin-1-yl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro -4-oxoquinoline-3-carboxylic acids, 14-25, were studied to clarify the structural requirements for 3-substituted azetidi